Your browser doesn't support javascript.
loading
Anti-SARS-CoV-2 and Autoantibody Profiling of a COVID-19 Patient With Subacute Psychosis Who Remitted After Treatment With Intravenous Immunoglobulin.
McAlpine, Lindsay S; Lifland, Brooke; Check, Joseph R; Angarita, Gustavo A; Ngo, Thomas T; Chen, Peixi; Dandekar, Ravi; Alvarenga, Bonny D; Browne, Weston D; Pleasure, Samuel J; Wilson, Michael R; Spudich, Serena S; Farhadian, Shelli F; Bartley, Christopher M.
Affiliation
  • McAlpine LS; Department of Neurology, Yale University School of Medicine, New Haven, Connecticut.
  • Lifland B; Department of Psychiatry, Yale University School of Medicine, New Haven, Connecticut.
  • Check JR; Department of Psychiatry, Yale University School of Medicine, New Haven, Connecticut.
  • Angarita GA; Department of Psychiatry, Yale University School of Medicine, New Haven, Connecticut.
  • Ngo TT; Weill Institute for Neurosciences, University of California, San Francisco, California; Department of Psychiatry and Behavioral Sciences, University of California, San Francisco, California.
  • Chen P; Weill Institute for Neurosciences, University of California, San Francisco, California; Department of Neurology, University of California, San Francisco, California.
  • Dandekar R; Weill Institute for Neurosciences, University of California, San Francisco, California; Department of Neurology, University of California, San Francisco, California.
  • Alvarenga BD; Weill Institute for Neurosciences, University of California, San Francisco, California; Department of Neurology, University of California, San Francisco, California.
  • Browne WD; Weill Institute for Neurosciences, University of California, San Francisco, California; Department of Neurology, University of California, San Francisco, California.
  • Pleasure SJ; Weill Institute for Neurosciences, University of California, San Francisco, California; Department of Neurology, University of California, San Francisco, California.
  • Wilson MR; Weill Institute for Neurosciences, University of California, San Francisco, California; Department of Neurology, University of California, San Francisco, California.
  • Spudich SS; Department of Neurology, Yale University School of Medicine, New Haven, Connecticut.
  • Farhadian SF; Department of Internal Medicine, Section of Infectious Diseases, Yale School of Medicine, New Haven, Connecticut.
  • Bartley CM; Weill Institute for Neurosciences, University of California, San Francisco, California; Department of Psychiatry and Behavioral Sciences, University of California, San Francisco, California. Electronic address: chris.bartley@nih.gov.
Biol Psychiatry ; 93(9): e25-e29, 2023 05 01.
Article de En | MEDLINE | ID: mdl-36481066

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Troubles psychotiques / COVID-19 Limites: Humans Langue: En Journal: Biol Psychiatry Année: 2023 Type de document: Article Pays de publication: États-Unis d'Amérique

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Troubles psychotiques / COVID-19 Limites: Humans Langue: En Journal: Biol Psychiatry Année: 2023 Type de document: Article Pays de publication: États-Unis d'Amérique